United States Court of Appeals for the Federal Circuit

Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, November 7, 2023
Type, United Therapeutics, United States District Court for the Eastern District of Texas, FDA, Research, Sale, New Drug Application, Drug Price Competition and Patent Term Restoration Act, IND, PDUFA, Food, Patent, CAFC, Silicon, PRINT, Prescription Drug User Fee Act, Security, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Certification, Peru–United States Trade Promotion Agreement, Orthostatic hypertension, The Orange Book, United States Court of Appeals for the Federal Circuit, Orange Book, Promotion, UTHR, Pulmonary hypertension, District court, Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Patent Trial and Appeal Board, Douglas v. U.S. District Court ex rel Talk America, PAH, Lender option borrower option, NDA, PTAB, Patient, Treprostinil, Pharmaceutical industry, Cryptocurrency

Oral arguments in appeal of ‘793 PTAB decision set for December 4, 2023

Key Points: 
  • Oral arguments in appeal of ‘793 PTAB decision set for December 4, 2023
    PDUFA goal date to add PH-ILD indication to YUTREPIA label is January 24, 2024
    MORRISVILLE, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) today reported financial results for the third quarter ended September 30, 2023.
  • ET to discuss the financial results and provide a corporate update.
  • Cash totaled $76.2 million as of September 30, 2023, compared to $93.3 million as of December 31, 2022.
  • Total other expense, net was $0.9 million for the three months ended September 30, 2023, compared with $0.3 million for the three months ended September 30, 2022.

Miller Barondess Expands IP Litigation Practice

Retrieved on: 
Wednesday, November 1, 2023
Professional Services, Legal, Patent Law, Insurance, University of Colorado Law School, Sport, Patent, Arizona State University, Theft, Government, Face, Inter partes review, Intellectual property, United States Court of Appeals for the Federal Circuit, Multimedia, Patent office, LLP, Partnership, Kirkland & Ellis, Sandra, University, Health, Lawyer, 3D printing, IP

Miller Barondess, LLP adds top patent and trade secret litigator Ben Herbert to its partnership, continuing the expansion of the firm's Intellectual Property practice.

Key Points: 
  • Miller Barondess, LLP adds top patent and trade secret litigator Ben Herbert to its partnership, continuing the expansion of the firm's Intellectual Property practice.
  • Adding his patent expertise to the IP team further enhances the firm's already robust IP practice and solidifies its position as a powerhouse in IP litigation.
  • "We are very pleased to have Ben working with us as the firm continues to grow," said Skip Miller, a founding partner of Miller Barondess.
  • Miller Barondess is a Los Angeles-based firm specializing in litigation, trial, and appellate work in California and around the country.

Heim, Payne & Chorush in Houston Earns National Best Law Firms Recognition

Retrieved on: 
Thursday, November 2, 2023
Patent, Patent Trial and Appeal Board, Intellectual property, United States Court of Appeals for the Federal Circuit, Tier 1, LLP, District court, Patexia, Douglas v. U.S. District Court ex rel Talk America, Lawyer, Heim, Tobacco

HOUSTON, Nov. 2, 2023 /PRNewswire/ -- The experienced attorneys at Houston's Heim, Payne & Chorush, LLP , have propelled the firm to national and local rankings on the 2024 Best Law Firms list from the publishers of The Best Lawyers in America.

Key Points: 
  • HOUSTON, Nov. 2, 2023 /PRNewswire/ -- The experienced attorneys at Houston's Heim, Payne & Chorush, LLP , have propelled the firm to national and local rankings on the 2024 Best Law Firms list from the publishers of The Best Lawyers in America.
  • Led by name partners Michael Heim , Leslie Payne , and Russell Chorush , Heim, Payne & Chorush is ranked among the nation's top firms for intellectual property and patent litigation and Tier 1 among Houston's best law firms for the same types of cases.
  • Heim, Payne & Chorush has successfully represented companies and individuals from various industries with significant intellectual property and patent disputes for nearly two decades.
  • The attorneys at Heim, Payne & Chorush are closing out 2023 with one of the best years in the firm's history.

NCLA Asks D.C. District Court to Halt Illegal Suspension of Hon. Pauline Newman

Retrieved on: 
Thursday, October 26, 2023
Montana District Courts, Heart, NCLA, Congress, Judiciary, United States Court of Appeals for the Federal Circuit, Judicial council (United States), Hon, Judicial Council, District court, Douglas v. U.S. District Court ex rel Talk America, Federal, United States Court of Appeals for the Fifth Circuit, Hearing

Pauline Newman’s complaint and to grant a preliminary injunction halting her ongoing suspension.

Key Points: 
  • Pauline Newman’s complaint and to grant a preliminary injunction halting her ongoing suspension.
  • In March 2023, the Judicial Council indefinitely suspended Judge Newman from hearing new cases before any formal investigation began.
  • The District Court should reject Defendants’ claims of absolute and unfettered power to effectively remove judges from office—a power that belongs to Congress alone.”
    “Judge Newman has a clear right to review in the District Court.
  • We look forward to continuing to work in this court to ensure a fair and constitutional process for Judge Newman and other Article III judges—and to see Judge Newman returned to hearing cases as soon as possible.”

USPTO Lead Administrative Patent Judge Kit Crumbley Joins Bracewell's IP Litigation Practice in Austin

Retrieved on: 
Monday, October 23, 2023
Rice University, Patent, United States Court of Federal Claims, Government, Patent Trial and Appeal Board, University, Intellectual property, United States Court of Appeals for the Federal Circuit, Leahy–Smith America Invents Act, Justice, AIA, Kit, Crumbley, Finnegan, Henderson, Farabow, Garrett & Dunner, Bracewell, Finnegan, Virginia School for Girls, Chemistry, IP, Virginia Law Review, Bracewell LLP, Pharmaceutical industry, PTAB

Austin, Texas--(Newsfile Corp. - October 23, 2023) - Bracewell LLP announced today that Christopher L. ("Kit") Crumbley has joined the firm's intellectual property litigation team as a partner in the Austin office.

Key Points: 
  • Austin, Texas--(Newsfile Corp. - October 23, 2023) - Bracewell LLP announced today that Christopher L. ("Kit") Crumbley has joined the firm's intellectual property litigation team as a partner in the Austin office.
  • Crumbley most recently was a Lead Administrative Judge at the United States Patent & Trademark Office's Patent Trial & Appeal Board (PTAB).
  • "Kit's extensive experience and technical background, including his many years in PTAB leadership, bring additional depth and resources to our successful IP litigation team."
  • He joined the Patent Trial & Appeal Board in 2012, serving as an administrative patent judge before his promotion to a Lead Administrative Patent Judge in 2017.

Veteran Service Organizations File Lawsuit to Compel VA to Amend its Character of Discharge Regulations

Retrieved on: 
Wednesday, October 25, 2023
Post-traumatic stress disorder, U.S. Department of Veterans Affairs, Office of Inspector General, Suicide, Survivor, Housing, Texas Legal Services Center, Congress, Harvard Law School, Face, LGBTQ, Court, Lawsuit, Veteran, United States Court of Appeals for the Federal Circuit, Trauma, Honoring our PACT Act of 2022, PTSD, Character, Disability, Burn, PACT Act, Marines, MST, PACT, Real estate, Nursing, Hospital, Sword

Washington, D.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Today, two veterans service organizations filed a lawsuit in the U.S. Court of Appeals for the Federal Circuit to compel the U.S. Department of Veterans Affairs (VA) to issue regulations amending the VA’s Character of Discharge process.

Key Points: 
  • Washington, D.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Today, two veterans service organizations filed a lawsuit in the U.S. Court of Appeals for the Federal Circuit to compel the U.S. Department of Veterans Affairs (VA) to issue regulations amending the VA’s Character of Discharge process.
  • Under the current rules, thousands of veterans with less than honorable discharges are unjustly denied VA benefits.
  • Less than honorable discharges often result from minor disciplinary infractions that are symptomatic of trauma or experiences of injustice during military service.
  • Joseph Effiong, a Marine Corps combat veteran who deployed twice to Iraq, was denied VA benefits because of his less than honorable discharge and the regulations that the VA long ago agreed to amend.

Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation

Retrieved on: 
Friday, October 20, 2023
United States Court of Appeals for the Federal Circuit, Patent, Vanda, Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Teleflex, Public, Pharmacy, Apotex Inc v Sanofi-Synthelabo Canada Inc, Patient, Generic drug

Vanda's petition seeks to show that the Federal Circuit's approach to obviousness has deviated materially from KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398, 416 (2007), which trains the obviousness inquiry on whether the claimed innovations "do more than yield a predictable result."

Key Points: 
  • Vanda's petition seeks to show that the Federal Circuit's approach to obviousness has deviated materially from KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398, 416 (2007), which trains the obviousness inquiry on whether the claimed innovations "do more than yield a predictable result."
  • Vanda believes that the Federal Circuit's approach improperly invalidates critical patent rights, which are necessary to ensure robust pharmaceutical research and development.
  • "Properly calibrated patent protection is essential to pharmaceutical innovation, which is in turn critical for advances in public health.
  • Chief Justice Roberts extended the time for the filing of Vanda's forthcoming petition, which Vanda expects to file by January 12, 2024.

Attorneys from Houston's Heim, Payne & Chorush Earn National Trial Lawyer Rankings

Retrieved on: 
Thursday, October 5, 2023
Patent, Judgement, Douglas v. U.S. District Court ex rel Talk America, Apple Inc., Patexia, PTAB, LLP, United States Court of Appeals for the Federal Circuit, Patent Trial and Appeal Board, District court, Samsung Electronics, Lawyer, Quanta Computer, Inc. v. LG Electronics, Inc., Electronics, Wells Fargo, Generic drug, Private investigator, Ridesharing, Tobacco

HOUSTON, Oct. 5, 2023 /PRNewswire/ -- A group of attorneys from Houston-based Heim, Payne & Chorush, LLP , are recognized for their trial skills in The 2024 Lawdragon 500 Leading Litigators in America listing.

Key Points: 
  • HOUSTON, Oct. 5, 2023 /PRNewswire/ -- A group of attorneys from Houston-based Heim, Payne & Chorush, LLP , are recognized for their trial skills in The 2024 Lawdragon 500 Leading Litigators in America listing.
  • Firm leaders Michael Heim , Leslie Payne , and Russell Chorush are included in the exclusive listing for intellectual property law and patent disputes.
  • Mr. Chorush is additionally recognized for his expertise in antitrust law.
  • Fellow firm partners Allan Bullwinkel and Eric Enger earned spots on the Lawdragon roster of the country's top trial lawyers based on their work in patent cases.

Goulston & Storrs Attorneys Joshua Davis, Elizabeth Levine, and Carla Reeves Named to 2024 Lawdragon 500 Leading Corporate Employment Lawyers

Retrieved on: 
Thursday, October 5, 2023
United States Court of Appeals for the Federal Circuit, United States Court of Appeals for the Tenth Circuit, Corporate America, Chambers, Philippine Senate Committee on Labor, Employment and Human Resources Development, College, Boston (magazine), University of Chicago Law School, Employment, Boston College Law School, University, Massachusetts Commission Against Discrimination, The National Law Journal, Chambers and Partners, Workforce, Lawyer, Labour law, Hon, Suffolk University Law School, Labour, Nursing

Joshua Davis is one of the country's leading employment lawyers.

Key Points: 
  • Joshua Davis is one of the country's leading employment lawyers.
  • Davis is a Fellow of the College of Labor and Employment Lawyers and a Board Member of the American Employment Law Council.
  • She was named a Go To Employment Lawyer by Massachusetts Lawyers Weekly (2023), a Top Employment Lawyer by Boston Magazine (2021-2022), and an Employment Law Trailblazer by The National Law Journal (2020).
  • She was named an Employment Law Trailblazer by The National Law Journal (2021) and a Top Employment Lawyer by Boston Magazine (2021 and 2023).

Supreme Court Denies CareDx Request for Appeal in Patent Case with Natera

Retrieved on: 
Tuesday, October 3, 2023
Oncology, Health, Genetics, Other Health, Research, Science, Biotechnology, DNA, United States Court of Appeals for the Federal Circuit, Nucleic acid thermodynamics, District court, Patent, Supreme court, Law of the United Kingdom, CDNA, NTRA, Natera

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that the United States Supreme Court denied CareDx, Inc.’s (NASDAQ: CDNA) petition for certiorari concerning a patent infringement lawsuit brought by CareDx against Natera.

Key Points: 
  • Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that the United States Supreme Court denied CareDx, Inc.’s (NASDAQ: CDNA) petition for certiorari concerning a patent infringement lawsuit brought by CareDx against Natera.
  • A June 2022 decision by the United States Court of Appeals for the Federal Circuit, affirming the Delaware Court’s decision.
  • A December 2022 denial of rehearing by the United States Court of Appeals for the Federal Circuit.
  • This final decision by the Supreme Court rejects the request by CareDx to litigate this matter once again and effectively terminates any existing claims brought by CareDx against Natera concerning these patents.